238 related articles for article (PubMed ID: 27009368)
1. Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses.
Pappalardo M; Juliá M; Howard MJ; Rossman JS; Michaelis M; Wass MN
Sci Rep; 2016 Mar; 6():23743. PubMed ID: 27009368
[TBL] [Abstract][Full Text] [Related]
2. Investigating Ebola virus pathogenicity using molecular dynamics.
Pappalardo M; Collu F; Macpherson J; Michaelis M; Fraternali F; Wass MN
BMC Genomics; 2017 Aug; 18(Suppl 5):566. PubMed ID: 28812539
[TBL] [Abstract][Full Text] [Related]
3. VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability.
Schwarz TM; Edwards MR; Diederichs A; Alinger JB; Leung DW; Amarasinghe GK; Basler CF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974555
[TBL] [Abstract][Full Text] [Related]
4. Is the Bombali virus pathogenic in humans?
Martell HJ; Masterson SG; McGreig JE; Michaelis M; Wass MN
Bioinformatics; 2019 Oct; 35(19):3553-3558. PubMed ID: 31093647
[TBL] [Abstract][Full Text] [Related]
5. The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.
Zhang AP; Bornholdt ZA; Liu T; Abelson DM; Lee DE; Li S; Woods VL; Saphire EO
PLoS Pathog; 2012 Feb; 8(2):e1002550. PubMed ID: 22383882
[TBL] [Abstract][Full Text] [Related]
6. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.
Reid SP; Valmas C; Martinez O; Sanchez FM; Basler CF
J Virol; 2007 Dec; 81(24):13469-77. PubMed ID: 17928350
[TBL] [Abstract][Full Text] [Related]
7. Changes associated with Ebola virus adaptation to novel species.
Pappalardo M; Reddin IG; Cantoni D; Rossman JS; Michaelis M; Wass MN
Bioinformatics; 2017 Jul; 33(13):1911-1915. PubMed ID: 28200119
[TBL] [Abstract][Full Text] [Related]
8. Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.
Ramanathan P; Tigabu B; Santos RI; Ilinykh PA; Kuzmina N; Vogel OA; Thakur N; Ahmed H; Wu C; Amarasinghe GK; Basler CF; Bukreyev A
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243162
[TBL] [Abstract][Full Text] [Related]
9. An all-atom molecular dynamics study of the anti-interferon signaling of Ebola virus: interaction mechanisms of EBOV VP24 binding to Karyopherin alpha5.
Ding JN; Zhang YJ; Zhong H; Ao CC; Li J; Han JG
Mol Biosyst; 2017 May; 13(5):1031-1045. PubMed ID: 28418440
[TBL] [Abstract][Full Text] [Related]
10. Serological evidence of exposure to ebolaviruses in domestic pigs from Guinea.
Fischer K; Camara A; Troupin C; Fehling SK; Strecker T; Groschup MH; Tordo N; Diederich S
Transbound Emerg Dis; 2020 Mar; 67(2):724-732. PubMed ID: 31627257
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Ebola Virus VP24 Protein by SUMO.
Vidal S; El Motiam A; Seoane R; Preitakaite V; Bouzaher YH; Gómez-Medina S; San Martín C; Rodríguez D; Rejas MT; Baz-Martínez M; Barrio R; Sutherland JD; Rodríguez MS; Muñoz-Fontela C; Rivas C
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597768
[TBL] [Abstract][Full Text] [Related]
12. The ebolavirus VP24 interferon antagonist: know your enemy.
Zhang AP; Abelson DM; Bornholdt ZA; Liu T; Woods VL; Saphire EO
Virulence; 2012 Aug; 3(5):440-5. PubMed ID: 23076242
[TBL] [Abstract][Full Text] [Related]
13. Risks Posed by Reston, the Forgotten Ebolavirus.
Cantoni D; Hamlet A; Michaelis M; Wass MN; Rossman JS
mSphere; 2016; 1(6):. PubMed ID: 28066813
[TBL] [Abstract][Full Text] [Related]
14. Ebolaviruses: New roles for old proteins.
Cantoni D; Rossman JS
PLoS Negl Trop Dis; 2018 May; 12(5):e0006349. PubMed ID: 29723187
[TBL] [Abstract][Full Text] [Related]
15. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.
Watt A; Moukambi F; Banadyga L; Groseth A; Callison J; Herwig A; Ebihara H; Feldmann H; Hoenen T
J Virol; 2014 Sep; 88(18):10511-24. PubMed ID: 24965473
[TBL] [Abstract][Full Text] [Related]
16. Structure of the Reston ebolavirus VP30 C-terminal domain.
Clifton MC; Kirchdoerfer RN; Atkins K; Abendroth J; Raymond A; Grice R; Barnes S; Moen S; Lorimer D; Edwards TE; Myler PJ; Saphire EO
Acta Crystallogr F Struct Biol Commun; 2014 Apr; 70(Pt 4):457-60. PubMed ID: 24699737
[TBL] [Abstract][Full Text] [Related]
17. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
Guito JC; Albariño CG; Chakrabarti AK; Towner JS
Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
[TBL] [Abstract][Full Text] [Related]
18. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling.
Mateo M; Reid SP; Leung LW; Basler CF; Volchkov VE
J Virol; 2010 Jan; 84(2):1169-75. PubMed ID: 19889762
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.
Yamaoka S; Ebihara H
Virulence; 2021 Dec; 12(1):885-901. PubMed ID: 33734027
[TBL] [Abstract][Full Text] [Related]
20. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
